Skip to main content
. 2021 May 21;22(11):5443. doi: 10.3390/ijms22115443

Figure 4.

Figure 4

A33 dosing does not produce any carry-over effects the day following injection. Comparison of the average baseline alcohol intake exhibited by (A) B6NJ and (B) B6J mice and the total alcohol intake exhibited the day following each A33 injection (Post-A33). The data represent the mean ± SEM of the number of mice indicated in parentheses, as well as the individual data points for each drinking day.